General Infectious Diseases Clinical Research and COVID

The Washington University Infectious Diseases Clinical Research Unit ( ID-CRU) is known for its expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to general Infectious Diseases research opportunities, community outreach and education. Our lead faculty in these areas are:

Associate Professor of Medicine

Phone314-454-8215

Fax314-454-5392

Emailrpresti@wustl.edu

Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.

Assistant Professor of Medicine

Phone3144548354

Emailjaneaohalloran@wustl.edu

Dr. O’Halloran specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.

Instructor in Medicine

Phone314-454-8254

Emaila.rauseoacevedo@wustl.edu

Dr. Rauseo specializes in clinical infectious diseases, with a special focus on mycology and infectious that affect immunocompromised hosts. Since the outset of the COVID-19 pandemic she has served as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU) in multiple clinical trials and translational research in the fight against COVID-19.

Assistant Professor of Medicine

Phone314-454-8354

Fax314-454-5392

Emailaspec@wustl.edu

Dr. Spec ‘s research is in fungal infections, particularly in immunocompromised patients, including those with transplants. His research focuses on Cryptococcus, Histoplasma, Candida, Aspergillus and other invasive molds.  Dr. Spec also runs the division’s clinic focusing on invasive fungal infections, where he takes care of both immunocompromised and immunocompetent patients with fungal infections, which he considers the best and most rewarding part of his job.

Instructor in Medicine

Emailmhendrix@wustl.edu

Dr. Hendrix specializes in antimicrobial stewardship and clinical infectious disease with a special focus on COVID-19 and bone marrow transplant (BMT) recipients.

Clinical Trials

COVID-19 STUDIES